Webflow Homepage
Veterinarians
Services For
Canine lymphoma & Leukemia
Personalized Prediction Profile
AI-Driven Drug Response Predictions
(Flow Cytometry + PARR included)
Drug Response Predictions
NEW
Personalize anticancer drug treatment decisions with confidence
Immunoprofile
Get accurate diagnostic support from the start (Flow Cytometry + PARR)
Flow Cytometry
Accurately determine lymphoma or leukemia subtypes
PARR
Detect neoplastic B-cell or T-cell clones
Multidrug Sensitivity Genotyping (MDR1)
Identify MDR1 carrier status with ease
Services For
FELINE lymphoma & Leukemia
Immunoprofile
Get accurate diagnostic support from the start (PARR + Flow Cytometry)
Flow Cytometry
Accurately determine lymphoma or leukemia subtypes
PARR
Detect neoplastic B-cell or T-cell clones
for
veterinarians
Order Services via Vet Portal
Request Sample Reports
See what you will get when you order ImpriMed's services
Request Pricing
Become an ImpriMed Provider
Participate in Our Research
Veterinary Cancer Pioneers Podcast
Contact Us
Pet Parents
LEARN
How It Works
Dog Lymphoma 101
Cat Lymphoma 101
Blog
Content Library
Get Started
Find a Veterinary Oncologist
Talk to Your Veterinarian
Customer stories & Case Studies
ImpriMed Reviews
Discover what other pet parents are saying and how oncologists use ImpriMed's reports
Human Oncology
CRO
Company
Company
Our Science
About Us
Careers
Events
Press
Contact Us
Contact Us
Other Links
ImpriMed Korea
Pricing
Language
日本語 (Japanese)
English (International)
日本語 (Japanese)
English (International)
Find a Vet
Get Started
Press
Newsroom
Contact
press@imprimedicine.com
Follow
Download
Press Kit
Featured articles
TechCrunch
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
Read More →
USA Today
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
Read More →
International Business Times
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
Read More →
MedCity News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
Read More →
Latest Stories
Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
Press Releases
ImpriMed AI and machine learning is disrupting the veterinary oncology tools available for better treatment outcomes
EIN Presswire
Learn More →
Presentations
Precision medicine for pet cancer care
Animal Health, Nutrition and Technology Innovation Europe 2022
Learn More →
Press Releases
ImpriMed Publishes Exclusive Canine Patients Data Analysis
EIN Presswire
Learn More →
In the News
AI’s Computing Power Could Make Fusion Energy Practical
Lifewire
Learn More →
Press Releases
ImpriMed CEO and Co-founder Dr. Sungwon Lim Wins Prestigious “Top Industry Leader” Award from Life Sciences Voice
EIN Presswire
Learn More →
Press Releases
ImpriMed Reports Significant Growth in 2021 with Pre-Series A Funding, New Product Launches, and Team Expansion
EIN Presswire
Learn More →
Video/Podcast Interviews
Personalized Medicine in Veterinary Oncology
Veterinary Innovation Podcast
Learn More →
In the News
Don't Guess Your Pet's Condition, Treat It with ImpriMed
Startup to Follow
Learn More →
Scientific Publications
Predicting Dynamic Clinical Outcomes of the Chemotherapy for Canine Lymphoma Patients Using a Machine Learning Model
Veterinary Sciences
Learn More →
Presentations
Predicting dynamic clinical outcomes of (L-)CHOP chemotherapy for canine lymphoma patients using an artificial intelligence model
Veterinary Cancer Society Annual Conference 2021
Learn More →
Presentations
ImpriMed: Experiences from the eyes of an oncologist in clinical practice
Veterinary Cancer Society Annual Conference 2021
Learn More →
Press Releases
ImpriMed Launches New Diagnostic Services for Canine Lymphoma
EIN Presswire
Learn More →
In the News
Interview with ImpriMed CEO & Co-Founder Sungwon Lim
IdeaMensch
Learn More →
Video/Podcast Interviews
Interview with Dr. Sungwon Lim, CEO of ImpriMed
Innovating with Scott Amyx
Learn More →
Video/Podcast Interviews
Tech Founder Interview with Sungwon Lim, CEO & Founder of ImpriMed
Tech Founder Show by Insivia
Learn More →
Press Releases
ImpriMed Initiates Feline Lymphoma Drug Response Prediction Study
EIN Presswire
Learn More →
In the News
This Test Might Make All The Difference When Fighting Lymphoma
Canine Cancer Alliance
Learn More →
Press Releases
ImpriMed Launches Chemo Response Prediction and Immunophenotyping Services for Canine Lymphoma
GlobeNewswire
Learn More →
Previous
Next